Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
Han-Lin Chiang, Chin-Hsien Lin
JMD. 2019;12(2):67-83.   Published online 2019 May 30     DOI: https://doi.org/10.14802/jmd.18067
Citations to this article as recorded by Crossref logo
Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
Justin Cho, You Jeong Park, Bella Gonzales‐Portillo, Madeline Saft, Blaise Cozene, Nadia Sadanandan, Cesar V. Borlongan
CNS Neuroscience & Therapeutics.2021; 27(5): 505.     CrossRef
Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease
Szu-Ju Chen, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang, Chin-Hsien Lin
Journal of Parkinson's Disease.2021; : 1.     CrossRef
Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease
Bartłomiej Sankowski, Karolina Księżarczyk, Emilia Raćkowska, Stanisław Szlufik, Dariusz Koziorowski, Joanna Giebułtowicz
Clinica Chimica Acta.2020; 501: 165.     CrossRef
The microbiome-gut-brain axis in acute and chronic brain diseases
Corinne Benakis, Camille Martin-Gallausiaux, Jean-Pierre Trezzi, Philip Melton, Arthur Liesz, Paul Wilmes
Current Opinion in Neurobiology.2020; 61: 1.     CrossRef
The progress of gut microbiome research related to brain disorders
Sibo Zhu, Yanfeng Jiang, Kelin Xu, Mei Cui, Weimin Ye, Genming Zhao, Li Jin, Xingdong Chen
Journal of Neuroinflammation.2020;[Epub]     CrossRef
Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological Particularities
Ovidiu-Dumitru Ilie, Alin Ciobica, Jack McKenna, Bogdan Doroftei, Ioannis Mavroudis, Tuane B. Sampaio
Oxidative Medicine and Cellular Longevity.2020; 2020: 1.     CrossRef
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
Carolina Pellegrini, Luca Antonioli, Vincenzo Calderone, Rocchina Colucci, Matteo Fornai, Corrado Blandizzi
Progress in Neurobiology.2020; 191: 101806.     CrossRef
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno
Movement Disorders.2020; 35(9): 1626.     CrossRef
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Maria Fouka, Panagiota Mavroeidi, Grigoria Tsaka, Maria Xilouri
Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
Role of Carbon Monoxide in Host–Gut Microbiome Communication
Christopher P. Hopper, Ladie Kimberly De La Cruz, Kristin V. Lyles, Lauren K. Wareham, Jack A. Gilbert, Zehava Eichenbaum, Marcin Magierowski, Robert K. Poole, Jakob Wollborn, Binghe Wang
Chemical Reviews.2020; 120(24): 13273.     CrossRef
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Chrysoula Marogianni, Maria Sokratous, Efthimios Dardiotis, Georgios M. Hadjigeorgiou, Dimitrios Bogdanos, Georgia Xiromerisiou
International Journal of Molecular Sciences.2020; 21(22): 8421.     CrossRef
Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
Tennekoon B. Karunaratne, Chijioke Okereke, Marissa Seamon, Sharad Purohit, Chandramohan Wakade, Amol Sharma
Nutrients.2020; 13(1): 28.     CrossRef
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
Hiroshi Nishiwaki, Tomonari Hamaguchi, Mikako Ito, Tomohiro Ishida, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori, Ken Kurokawa, Masahisa Katsuno, Masaaki Hirayama, Kinji Ohno, Chaysavanh Manichanh
mSystems.2020;[Epub]     CrossRef
The Intestinal Barrier in Parkinson’s Disease: Current State of Knowledge
Sven C. D. van IJzendoorn, Pascal Derkinderen, Teus van Laar
Journal of Parkinson's Disease.2019; 9(s2): S323.     CrossRef
Medical management, prevention and mitigation of environmental risks factors in Neurology
J. Reis, G.C. Román, M. Giroud, V.S. Palmer, P.S. Spencer
Revue Neurologique.2019; 175(10): 698.     CrossRef
Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain
Yaoyu Pu, Lijia Chang, Youge Qu, Siming Wang, Kai Zhang, Kenji Hashimoto
Aging.2019; 11(17): 6915.     CrossRef